A Study of GenSci098 in Subjects With Active Thyroid Eye Disease

NCT06569758 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety
Tolerability
GenSci098
Thyroid Eye Disease (TED)

Interventions

DRUG: GenSci098
DRUG: GenSci098 Placebo

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.